CHA2DS2-VASC-HS SCORE AS A PREDICTOR OF SEVERITY OF CORONARY LESIONS, AND COMPLICATIONS OF PRIMARY PERCUTANEOUS CORONARY INTERVENTION FOR STEMI PATIENTS
DOI:
https://doi.org/10.47144/phj.v52i4.1824Abstract
Objective: To study if CHA2DS2-VASc-HS score can predict severity of coronarylesions, contrast induced nephropathy and new onset transient ischemic attack(TIA) or stroke during hospital admission in patients without atrial fibrillation(AFib) presented by STEMI and treated by primary PCI.
Methodology: We performed a cross-sectional study on STEMI patients treatedby primary PCI in cardiology department Tanta University hospital, Egyptbetween January 2016 and January 2018. CHA2DS2-VASc-HS score, Mahranrisk score and SYNTAX score were calculated for all patients excluding patientspresented with Afib. Occurrence of CIN, new-onset TIA or stroke and death wasnoted for all patients.
Results: About 179 STEMI patients were included. We found that CHA2DS2-VASc-HS score > 4 is associated with higher incidence of CIN P value (0.001),new-onset stroke or TIA P value (0.003) and death (0,001). Also Score from (0-2) has less incidence of occurrence of theses complication and the score > 4has higher incidence of complex coronary lesions P value (0.001).
Conclusion: CHA2DS2-VASc-HS score can be used as a good predictor ofcomplexity of coronary anatomy, in hospital mortality (CIN, new-onset TIA orStroke and death) in patients presented with STEMI.
Key Words: CHA2DS2-VASc-HS, ST elevation myocardial infarction,Complication
Downloads
Downloads
How to Cite
Issue
Section
License
When an article is accepted for publication in the print format, the author will be required to transfer exclusive copyright to the PHJ and retain the rights to use and share their published article with others. However, re-submission of the full article or any part for publication by a third party would require prior permission of the PHJ.
Online publication will allow the author to retain the copyright and share the article under the agreement described in the licensing rights with creative commons, with appropriate attribution to PHJ. Creative Commons attribution license CC BY 4.0 is applied to articles published in PHJ https://creativecommons.org/licenses/by/4.0/